Coherus BioSciences (CHRS) Tops Q3 EPS by 11c
Tweet
Share
E-mailGet Alerts CHRS Hot Sheet
Price: $1.33 -0.75%
Financial Fact:
Net income/(loss): 17.77M
Today's EPS Names:
JAGX, CLIR, ZTO, More
Financial Fact:
Net income/(loss): 17.77M
Today's EPS Names:
JAGX, CLIR, ZTO, More
Join SI Premium – FREE
Coherus BioSciences (NASDAQ: CHRS) reported Q3 EPS of ($0.27), $0.11 better than the analyst estimate of ($0.38). Revenue for the quarter came in at $74.6 million versus the consensus estimate of $81.78 million.
For earnings history and earnings-related data on Coherus BioSciences (CHRS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nordson Corp. (NDSN) Tops Q3 EPS by 16c; Offers Guidance
- Accuray (ARAY) Tops Q4 EPS by 1c
- Coty (COTY) Misses Q4 EPS by 1c, offers outlook
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
